EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine)
Saved in:
European Monitoring Centre for Drugs and Drug Addiction, Europol, EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine). Serie: EMCDDA-Europol Joint Reports, Luxemburgo, Publications Office of the European Union, 2014, 20 p.
Ref.
199607
Location:
SIIS Archivo
Palabras clave:
Detección, Drogas ilegales, Drogas legales, Drogodependencias, Efectos, Estimulantes, Evaluación, Informes oficiales, Innovaciones, Riesgo, Valoración, Unión Europea
Detección, Drogas ilegales, Drogas legales, Drogodependencias, Efectos, Estimulantes, Evaluación, Informes oficiales, Innovaciones, Riesgo, Valoración, Unión Europea
Similar Items: EMCDDA-Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine)
- EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’)
- EMCDDA-Europol Joint Report on a new psychoactive substance: AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide)
- EMCDDA-Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)
- 4,5 millones contra el tabaquismo
- 4,5 MILLONES CONTRA EL TABAQUISMO
- Un 4,5% presenta conductas suicidas